BJC Capital Advisors is an investment banking firm with an exclusive focus on the earlier-stage companies in the biopharmaceutical industry. We offer an integrated set of professional services tailored specifically to the unique needs of sector participants intended to optimize transaction outcomes.
Representative Transactions
Area of Expertise: Targeted Indications
BJC Capital Advisors has been involved in transactions across a broad array of disease indications including:
allergy and autoimmune disorders
cardio-renal
endocrine/metabolic
immunological disorders
infectious diseases
gastrointestinal
neurodegenerative disorders
neurological - pain management
neurological - addiction disorders
oncology
ophthalmology
orthopedic
precision medicine
rare disease
specialty pharmaceuticals
Area of Expertise: Therapeutic Treatment Modalities
Our engagements have spanned drugs and drug candidates utilizing a breadth of treatment modalities. Transaction experience has involved numerous therapeutic technologies including: